Michael Geffner

Insider Reports History

Location
New York, NY
Signature
/s/ Tiago Girao, attorney-in-fact for Michael Geffner
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Michael Geffner:

Company Role Class Num Shares Value Price $ Report Date Ownership
Immunovant, Inc. Chief Medical Officer Common Stock 217,958 $4,147,740 $19.03 22 Oct 2025 Direct
Immunovant, Inc. Chief Medical Officer Stock Option (right to buy) 143,063 01 Apr 2025 Direct

Insider Reports Filed by Michael Geffner

Symbol Company Period Transactions Value $ Form Type Role Filing Time
IMVT Immunovant, Inc. 22 Oct 2025 1 -$49,383 4 Chief Medical Officer 24 Oct 2025, 16:38
IMVT Immunovant, Inc. 08 Oct 2025 1 -$20,734 4 Chief Medical Officer 10 Oct 2025, 16:03
IMVT Immunovant, Inc. 23 Jul 2025 1 -$43,288 4 Chief Medical Officer 25 Jul 2025, 17:10
IMVT Immunovant, Inc. 09 Jul 2025 1 -$19,998 4 Chief Medical Officer 11 Jul 2025, 16:15
IMVT Immunovant, Inc. 23 Apr 2025 1 -$34,742 4 Chief Medical Officer 25 Apr 2025, 16:15
IMVT Immunovant, Inc. 09 Apr 2025 1 -$80,135 4 Chief Medical Officer 11 Apr 2025, 16:07
IMVT Immunovant, Inc. 01 Apr 2025 2 $0 4 Chief Medical Officer 03 Apr 2025, 16:50
IMVT Immunovant, Inc. 22 Jan 2025 1 -$62,679 4 Chief Medical Officer 24 Jan 2025, 16:22
IMVT Immunovant, Inc. 23 Oct 2024 1 -$94,171 4 Chief Medical Officer 25 Oct 2024, 16:23
IMVT Immunovant, Inc. 24 Jul 2024 1 -$95,939 4 Chief Medical Officer 26 Jul 2024, 16:19
IMVT Immunovant, Inc. 24 Apr 2024 1 -$94,243 4 Chief Medical Officer 26 Apr 2024, 17:22
IMVT Immunovant, Inc. 02 Apr 2024 2 $0 4 Chief Medical Officer 04 Apr 2024, 16:31
IMVT Immunovant, Inc. 26 Jan 2024 2 -$383,012 4 Chief Medical Officer 29 Jan 2024, 16:11
IMVT Immunovant, Inc. 16 Jan 2024 0 $0 3 Chief Medical Officer* 16 Jan 2024, 07:29